Biocon Limited (NSE:BIOCON)
India flag India · Delayed Price · Currency is INR
354.40
+3.90 (1.11%)
Jun 27, 2025, 3:30 PM IST

Biocon Statistics

Total Valuation

Biocon has a market cap or net worth of INR 409.74 billion. The enterprise value is 608.39 billion.

Market Cap 409.74B
Enterprise Value 608.39B

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date Jul 30, 2025
Ex-Dividend Date Jul 4, 2025

Share Statistics

Biocon has 1.20 billion shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class 1.20B
Shares Outstanding 1.20B
Shares Change (YoY) +0.11%
Shares Change (QoQ) +0.43%
Owned by Insiders (%) 56.08%
Owned by Institutions (%) 19.34%
Float 582.58M

Valuation Ratios

The trailing PE ratio is 40.43 and the forward PE ratio is 51.28. Biocon's PEG ratio is 1.33.

PE Ratio 40.43
Forward PE 51.28
PS Ratio 2.68
PB Ratio 1.48
P/TBV Ratio n/a
P/FCF Ratio 21.29
P/OCF Ratio 10.09
PEG Ratio 1.33
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.84, with an EV/FCF ratio of 31.61.

EV / Earnings 60.04
EV / Sales 3.99
EV / EBITDA 18.84
EV / EBIT 39.43
EV / FCF 31.61

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.66.

Current Ratio 1.14
Quick Ratio 0.71
Debt / Equity 0.66
Debt / EBITDA 5.77
Debt / FCF 9.54
Interest Coverage 1.74

Financial Efficiency

Return on equity (ROE) is 5.40% and return on invested capital (ROIC) is 2.20%.

Return on Equity (ROE) 5.40%
Return on Assets (ROA) 1.68%
Return on Invested Capital (ROIC) 2.20%
Return on Capital Employed (ROCE) 3.47%
Revenue Per Employee 9.35M
Profits Per Employee 621,085
Employee Count 16,315
Asset Turnover 0.27
Inventory Turnover 1.22

Taxes

In the past 12 months, Biocon has paid 4.57 billion in taxes.

Income Tax 4.57B
Effective Tax Rate 24.23%

Stock Price Statistics

The stock price has increased by +0.64% in the last 52 weeks. The beta is 0.22, so Biocon's price volatility has been lower than the market average.

Beta (5Y) 0.22
52-Week Price Change +0.64%
50-Day Moving Average 337.71
200-Day Moving Average 347.45
Relative Strength Index (RSI) 59.27
Average Volume (20 Days) 6,273,557

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Biocon had revenue of INR 152.62 billion and earned 10.13 billion in profits. Earnings per share was 8.46.

Revenue 152.62B
Gross Profit 92.44B
Operating Income 15.43B
Pretax Income 18.87B
Net Income 10.13B
EBITDA 31.24B
EBIT 15.43B
Earnings Per Share (EPS) 8.46
Full Income Statement

Balance Sheet

The company has 45.65 billion in cash and 183.62 billion in debt, giving a net cash position of -137.97 billion or -115.16 per share.

Cash & Cash Equivalents 45.65B
Total Debt 183.62B
Net Cash -137.97B
Net Cash Per Share -115.16
Equity (Book Value) 277.13B
Book Value Per Share 180.66
Working Capital 19.52B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 40.61 billion and capital expenditures -21.37 billion, giving a free cash flow of 19.25 billion.

Operating Cash Flow 40.61B
Capital Expenditures -21.37B
Free Cash Flow 19.25B
FCF Per Share 16.06
Full Cash Flow Statement

Margins

Gross margin is 60.57%, with operating and profit margins of 10.11% and 6.64%.

Gross Margin 60.57%
Operating Margin 10.11%
Pretax Margin 12.36%
Profit Margin 6.64%
EBITDA Margin 20.47%
EBIT Margin 10.11%
FCF Margin 12.61%

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.15%.

Dividend Per Share 0.50
Dividend Yield 0.15%
Dividend Growth (YoY) -66.67%
Years of Dividend Growth n/a
Payout Ratio 5.92%
Buyback Yield -0.11%
Shareholder Yield 0.03%
Earnings Yield 2.47%
FCF Yield 4.70%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 12, 2019. It was a forward split with a ratio of 2.

Last Split Date Jun 12, 2019
Split Type Forward
Split Ratio 2

Scores

Biocon has an Altman Z-Score of 1.63 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.63
Piotroski F-Score 6